Surrogate End Points in Pulmonary Arterial Hypertension: Assessing the Response to Therapy
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine
Reference111 articles.
1. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives;Hoeper;J Am Coll Cardiol,2004
2. End points in pulmonary arterial hypertension: the way forward;Peacock;Eur Respir J,2004
3. Surrogate end points for pulmonary arterial hypertension;Kawut;Am Heart J,2004
4. New answers raise new questions in pulmonary arterial hypertension;Kawut;Eur Respir J,2004
5. The current treatment of pulmonary arterial hypertension: time to redefine success;Rich;Chest,2006
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis;Vascular Pharmacology;2024-03
2. Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials;The Lancet Respiratory Medicine;2023-10
3. Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension;Pulmonary Circulation;2023-07
4. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension;Lung;2019-11-13
5. Pulmonary Vascular Disease;Exercise Physiology for the Pediatric and Congenital Cardiologist;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3